Yamada Tadataka 4
4 · Passage BIO, Inc. · Filed Mar 2, 2020
Insider Transaction Report
Form 4
Yamada Tadataka
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2020-02-27+33,836→ 33,836 totalExercise: $18.00Exp: 2030-02-27→ Common Stock (33,836 underlying)
Footnotes (1)
- [F1]The option vests as to 2.778% of the total shares monthly, commencing March 27, 2020, with 100% of the total shares vested on February 27, 2023, subject to the reporting person's provision of service to the issuer on each vesting date.